CRVS Q1 2026 Earnings EPS Misses Estimates Amid Ongoing Clinical Development UMC Q1 2026 Earnings Massive EPS Beat Signals Strong Operational Leverage LCTX Q1 2026 Earnings Widerthanexpected loss as clinicalstage biotech advances pipeline CSGP Q1 2026 Earnings EPS Surges 225 Above Expectations Amidst Modest Stock Decline LFCR Q1 2026 Earnings Wider Loss Than Expected Despite Positive Stock Reaction INUV Q1 2026 Earnings Strong EPS Beat Drives Stock Price Higher